Table 2 Potential cardiovascular benefits of DPP-4 inhibitors[38]
From: Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
Neutral effect on body weight | Improved glycemic control, including PPG reduction |
Decreased systolic blood pressure | Improved lipid profile |
Reduction in C-reactive protein (CRP) | Improvement of endothelial dysfunction |